Business
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan
NEW YORK--(BUSINESS WIRE)-- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and
About this update from Establishment Labs Holdings Inc.
[{"type":"text","content":" NEW YORK--(BUSINESS WIRE)--\nEstablishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into agreements with four partners in Europe and a second partner chain in Japan for Mia Femtech™ (“Mia®”).\n\n“Our global rollout of Mia Femtech continues, and we are pleased to announce our first European partners in Sweden, Switzerland, and Spain, as well as an additional chain in Japan,” said Juan José Chacón-Quirós, Founder and Chief Executive Officer. “We expect to partner with many more centers with a focus on creating premium experiences with broad appeal. Mia is opening breast aesthetics to a new group of consumers and the strong interest in partnering with us demonstrates the potential of Mia to dramatically expand our markets. We look forward to many more announcements on Mia over the coming weeks and months.”\n\nIn Stockholm, Sweden, Establishment Labs is partnering with Nordiska Kliniken, one of Scandinavia’s leading clinics in plastic surgery and aesthetic treatments. In Switzerland, the Company is working with Leman Aesthetic Clinic in Geneva and Clinic Utoquai in Zurich, which are both internationally recognized and well-established leaders in aesthetics. In Barcelona, Spain, Clínica Planas is well-known as a provider of premium services and outcomes in plastic surgery. Joe Clinic is a high-end medical aesthetics chain in Japan that will begin initially by offering Mia at its Tokyo and Osaka locations.\n\n“Mia Femtech will define a new premium aesthetic category with great potential for expanding the market,” said Javier Planas, CEO of Clínica Planas. “Clínica Planas has been a pioneer in aesthetics since 1971, and we are excited to once again be at the forefront of innovation and excellence.”\n\n“As leaders in plastic surgery, we are proud to introduce Mia Femtech as the coming evolution in breast aesthetics. Building Nordiska Kliniken has always been about innovating and this is the next natural step in our journey of being market leaders,” said Sam Besara, CEO of Nordiska Kliniken.\n\nMia Femtech is Establishment Labs’ breakthrough minimally invasive breast aesthetics experience. The patented technologies used with Mia can shape the breast up 1 to 2 cups in a 15-m...